OM
Insider buying
Opaleye Management Inc. bought $30K of Grace Therapeutics, Inc. (GRCE) stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 14,632 shares of GRCE stock worth $30K, per an SEC Form 4 filed Oct 13, 2026.
It was an open-market purchase.
The trade happened on Oct 8, 2026, 5 days before it was made public.
GRCE has moved -1.0% since the trade date, from $2.04 to $2.02 (Oct 12, 2026 close).
- Traded
- Oct 8, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 5 days
- Price since
- -1.0%
- Role
- 10% owner
- Source
- SEC Form 4
More GRCE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.